Hypothyroidism-associated rhabdomyolysis: A new case report and review of the reported cases

F. Khan, T. Sulaiman, R. Akbar
{"title":"Hypothyroidism-associated rhabdomyolysis: A new case report and review of the reported cases","authors":"F. Khan, T. Sulaiman, R. Akbar","doi":"10.4103/ijas.ijas_14_21","DOIUrl":null,"url":null,"abstract":"Background: Hypothyroidism alone or in combination with other factors has the risk of triggering rhabdomyolysis. In this article, we aim to describe hypothyroidism-associated rhabdomyolysis and its outcomes. Methods: We reported a new case of hypothyroidism-associated rhabdomyolysis and reviewed similar reported cases from the literature for in-depth knowledge. Results: Eighty-one cases, including the one reported in this article, met the inclusion criteria for this review. The mean age of the patients was 45.6 ± 15.8 years. Out of these, 57 (70.4%) patients were males and 24 (29.6%) were females. The precipitating factor was absent in 45 (55.6%) cases. A total of 8 (9.9%) cases had chronic renal failure at time of presentation, while 25 (30.9%) had hypertension, 11 (13.6%) had diabetes mellitus, and 32 (39.5%) had dyslipidemia. The median creatine kinase (CK) level was 5885 U/L (Interquartile range: 3280.5–11550.5 U/L). Electromyography was performed in 12 patients with 10 (12.3%) cases showing myopathic changes including polyphasic potential and fiber necrosis. Muscle biopsy was performed in 7 (8.4%) cases, with Type II fiber atrophy observed in 4 (4.9%) biopsies. Sixty-two cases developed acute kidney injury, of which 14 (17.3%) required hemodialysis. All patients were treated with levothyroxine and most patients (67, 82.7%) were treated by hydration. All the reported patients made good recovery. A statistically nonsignificant correlation was found between CK and thyroid-stimulating hormone (r = 0.218; P = 0.052). Conclusions: Rhabdomyolysis is a recognized complication of hypothyroidism even in the absence of additional risk factors. Clinicians should be aware of the impact of rhabdomyolysis and hypothyroidism on renal function and promptly initiate hormone replacement therapy and vigorous hydration to preserve the renal function.","PeriodicalId":192828,"journal":{"name":"Imam Journal of Applied Sciences","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Imam Journal of Applied Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijas.ijas_14_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Hypothyroidism alone or in combination with other factors has the risk of triggering rhabdomyolysis. In this article, we aim to describe hypothyroidism-associated rhabdomyolysis and its outcomes. Methods: We reported a new case of hypothyroidism-associated rhabdomyolysis and reviewed similar reported cases from the literature for in-depth knowledge. Results: Eighty-one cases, including the one reported in this article, met the inclusion criteria for this review. The mean age of the patients was 45.6 ± 15.8 years. Out of these, 57 (70.4%) patients were males and 24 (29.6%) were females. The precipitating factor was absent in 45 (55.6%) cases. A total of 8 (9.9%) cases had chronic renal failure at time of presentation, while 25 (30.9%) had hypertension, 11 (13.6%) had diabetes mellitus, and 32 (39.5%) had dyslipidemia. The median creatine kinase (CK) level was 5885 U/L (Interquartile range: 3280.5–11550.5 U/L). Electromyography was performed in 12 patients with 10 (12.3%) cases showing myopathic changes including polyphasic potential and fiber necrosis. Muscle biopsy was performed in 7 (8.4%) cases, with Type II fiber atrophy observed in 4 (4.9%) biopsies. Sixty-two cases developed acute kidney injury, of which 14 (17.3%) required hemodialysis. All patients were treated with levothyroxine and most patients (67, 82.7%) were treated by hydration. All the reported patients made good recovery. A statistically nonsignificant correlation was found between CK and thyroid-stimulating hormone (r = 0.218; P = 0.052). Conclusions: Rhabdomyolysis is a recognized complication of hypothyroidism even in the absence of additional risk factors. Clinicians should be aware of the impact of rhabdomyolysis and hypothyroidism on renal function and promptly initiate hormone replacement therapy and vigorous hydration to preserve the renal function.
甲状腺功能减退相关横纹肌溶解:新病例报告及报告病例回顾
背景:甲状腺功能减退或合并其他因素有引发横纹肌溶解的危险。在这篇文章中,我们的目的是描述甲状腺功能减退相关的横纹肌溶解及其结果。方法:我们报告了一例甲状腺功能减退症相关的横纹肌溶解症,并回顾了文献中类似的报道病例,以深入了解。结果:81例(包括本文报道的1例)符合本综述的纳入标准。患者平均年龄45.6±15.8岁。其中男性57例(70.4%),女性24例(29.6%)。45例(55.6%)无诱发因素。患者首发时有慢性肾功能衰竭8例(9.9%),高血压25例(30.9%),糖尿病11例(13.6%),血脂异常32例(39.5%)。肌酸激酶(CK)水平中位数为5885 U/L(四分位数范围为3280.5 ~ 11550.5 U/L)。12例患者行肌电图检查,其中10例(12.3%)显示肌病改变,包括多相电位和纤维坏死。肌肉活检7例(8.4%),II型纤维萎缩4例(4.9%)。62例发生急性肾损伤,其中14例(17.3%)需要血液透析。所有患者均采用左甲状腺素治疗,大部分患者(67,82.7%)采用水合治疗。所有病例均恢复良好。CK与促甲状腺激素的相关性无统计学意义(r = 0.218;P = 0.052)。结论:横纹肌溶解是甲状腺功能减退症的一种公认的并发症,即使没有其他危险因素。临床医生应意识到横纹肌溶解和甲状腺功能减退对肾功能的影响,并及时开始激素替代治疗和积极补水以保持肾功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信